Ernexa Therapeutics Inc Warrants (ERNAW)

$0.07 -0.03 (-30.00%)
Market Cap N/A
Revenue (ttm) 582,000.00
Net Income (ttm) -44.54M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -7,655.50%
Debt to Equity Ratio 0.28
Volume 50,000
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A
Latest News on ERNAW
No data available.